| Name: | Gatifloxacin Related Compound D |
| Catalogue No. | VL239004 |
| CAS No. | 112811-57-1 |
| Molecular Formula | C18H20FN3O4 |
| Molecular Weight | 361.37 |
| Status | In-stock |
| IUPAC Name | 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-hydroxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic Acid |
| Synonyms | 3-Desmethyl Gatifloxacin |
| Description | Gatifloxacin associated Compound D (CAS No: 112811-fifty seven-1 ) or 1-Cyclopropyl-6-fluoro-1,four-dihydro-8-hydroxy-7-(3-methyl-1-piperazinyl)-four-oxo-3-quinolinecarboxylic Acid is an adulteration of Gatifloxacin that is a 8-methoxy fluoroquinolone antibacterial agent.Gatifloxacin use in the remedy of network-acquired pneumonia (CAP), acute exacerbations of persistent bronchitis (AECB), acute sinusitis, simple and complex urinary tract infections (UTIs), pyelonephritis, gonorrhoea and uncompl |
| References | “Sci-Hub | Clinical Pharmacology of Gatifloxacin, a New Fluoroquinolone | 10.1086/314061.” Hkvisa.net, 2021, sci-hub.hkvisa.net/10.1086/314061. |
![Nitroso HPED [Nitroso hydroxy propylethyl diamine]](/public/site/files/site_images/thumb_nitroso-hped-nitroso-hydroxy-propylethyl-diamine46518.png)
